Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × milatuzumab × Clear all

NCT00421525 2021-08-16

Phase I/II Study of hLL1 in Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma, Plasmacytoma